Thoratec heartmate (R) left ventricular assist device for patients with heart failure who are ineligible for heart transplantation
Mundy L, Merlin T
Record ID 32006000572
English
Authors' results and conclusions:
Level II evidence indicates apparent survival benefits for the small target population (70 heart failure patients awaiting transplantation in Australia at January 2003, as well as the proportion ineligible for transplantation). It is expected that Heartmate Left Ventricular Assist Device (LVAD) will diffuse rapidly throughout the Australian health system.
Authors' recommendations:
HealthPACT recommends that a Horizon Scanning report be conducted.
Details
Project Status:
Completed
Year Published:
2003
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Heart Transplantation
- Heart Ventricles
- Heart-Assist Devices
- Heart Failure
- Ventricular Dysfunction
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.